Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2014
07/15/2014US8778351 Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors
07/15/2014US8778350 Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
07/15/2014US8778349 Modification of intrinsically disordered sequences for the preparation of vaccines
07/15/2014US8778348 Trypanosoma antigens, vaccine compositions, and related methods
07/15/2014US8778347 Fluorescent neutralization and adherence inhibition assays
07/15/2014US8778346 Anti-IL-23 antibodies
07/15/2014US8778345 Anti-CD40 antibodies
07/15/2014US8778344 Method of treating atopic dermatitis with antibody to zcytor17 ligand
07/15/2014US8778343 Antibodies that bind tau oligomers
07/15/2014US8778342 Antibody therapy
07/15/2014US8778341 Anti-CK8 antibodies to be used for treating colorectal cancers and identifying metastatic and/or invasive phenotypes
07/15/2014US8778340 Anti-angiogenesis therapy for the treatment of ovarian cancer
07/15/2014US8778339 Combination of FcγRIIB-specific antibodies and CD20-specific antibodies and methods of use thereof
07/15/2014US8778331 Method of determining susceptibility of a tumor cell to a chemotherapeutic agent: novel use of herpes simplex virus
07/15/2014US8778328 Poxviral oncolytic vectors
07/15/2014US8778307 Targeted carriers for drug delivery across the gastrointestinal epithelium
07/15/2014CA2782510C Polypeptides
07/15/2014CA2659353C Composition and method for treatment of tumors
07/15/2014CA2647455C Processes for the conjugation of poly n-acetylated glucosamine to a carrier protein
07/15/2014CA2620074C Canine influenza vaccines
07/15/2014CA2547126C Substance binding human igg fc receptor iib (fcyriib)
07/15/2014CA2526640C Immunogenic reagents from west nile virus
07/15/2014CA2526398C Human monoclonal antibodies against bacillus anthracis protective antigen
07/15/2014CA2520029C Slurp-1 compositions and methods of use thereof
07/15/2014CA2505583C Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods
07/15/2014CA2496485C Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis
07/10/2014WO2014107739A1 Antibodies against pcsk9
07/10/2014WO2014107731A1 Therapeutic vaccines for treating herpes simplex virus type 2 infections
07/10/2014WO2014107686A1 Methods for treating neuron damage
07/10/2014WO2014107657A2 Cholesterol-lowering compounds in combination with lipid metabolism-altering compounds of non-absorbable sugars, compounds that convert nh3 to nh4+, or hydrogen-generating compounds for the treatment of high cholesterol and inflammation
07/10/2014WO2014107652A2 Vaccines with higher carbohydrate antigen density and novel saponin adjuvant
07/10/2014WO2014107484A1 Methods for treating inflammation
07/10/2014WO2014107419A1 Use of oscillating gradients of high magnetic field for specific destruction of cells labeled with magnetic nanoparticles
07/10/2014WO2014107373A1 Methods for predicting time-to-delivery in pregnant women
07/10/2014WO2014107269A1 Secretory iga compositions, methods of making and methods of use thereof
07/10/2014WO2014107024A1 Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing same
07/10/2014WO2014107002A1 Lung cancer diagnostic marker
07/10/2014WO2014106886A1 Cdca5 peptides and vaccines containing the same
07/10/2014WO2014106798A2 Antimicrobial peptides, compositions comprising the same and uses thereof
07/10/2014WO2014106602A1 Antibodies that bind to tl1a and their uses
07/10/2014WO2014083232A9 Use of peptides or antibodies against n-procalcitonin for the treatment of pulmonary lesions
07/10/2014WO2014082729A9 Individualized vaccines for cancer
07/10/2014WO2014074540A3 Antibodies to s. aureus surface determinants
07/10/2014WO2014052713A3 Her2-and vegf-a-binding proteins with enhanced stability
07/10/2014WO2013082317A8 Recombinant gallid herpesvirus 3 (mdv serotype 2) vectors expressing antigens of avian pathogens and uses thereof
07/10/2014US20140194598 B7-related nucleic acids and polypeptides useful for immunomodulation
07/10/2014US20140193908 Sequential antibody therapy
07/10/2014US20140193488 In Situ Antigen-Generating Cancer Vaccine
07/10/2014US20140193486 Sustained releasing composition via local injection for treating eye diseases
07/10/2014US20140193484 Influenza virus immunogenic compositions and uses thereof
07/10/2014US20140193483 Therapeutic vaccines for treating herpes simplex virus type-2 infections
07/10/2014US20140193481 Stabilised vaccine composition
07/10/2014US20140193462 Methods for cancer treatment using stem cells
07/10/2014US20140193461 Streptococcus vaccine compositions and methods of using the same
07/10/2014US20140193460 Herpes virus vaccine and methods of use
07/10/2014US20140193459 Vaccine composition containing synthetic adjuvant
07/10/2014US20140193458 Method of vaccination comprising a histone deacetylase inhibitor
07/10/2014US20140193452 Novel agents for the prevention of leishmaniasis
07/10/2014US20140193451 Immunogenic composition
07/10/2014US20140193450 Peptide carrier fusion proteins as allergy vaccines
07/10/2014US20140193449 Compositions and methods for cancer treatment
07/10/2014US20140193448 Vaccine against multitypes of avian influenza viruses and uses thereof
07/10/2014US20140193447 Functional influenza virus-like particles (vlps)
07/10/2014US20140193446 Biodegradable high-efficiency dengue vaccine, method for making the same, and pharmaceutical composition comprising the same
07/10/2014US20140193445 Truncated Secretory Aspartyl Proteinase 2
07/10/2014US20140193444 Allergen peptide fragments and use thereof for treatment of dust mite allergies
07/10/2014US20140193441 Method of Administering Porcine B-domainless fVIII
07/10/2014US20140193439 Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same
07/10/2014US20140193434 Pharmaceutical composition for treatment and/or prophylaxis of cancer
07/10/2014US20140193428 Human cytomegalovirus neutralizing antibodies and use thereof
07/10/2014US20140193425 Treatment of cancer with alk1 antagonists
07/10/2014US20140193424 Method and medicament for inhibiting lymphangiogenesis
07/10/2014US20140193422 Fully human antibodies against human 4-1bb
07/10/2014US20140193417 Membrane Transporter NaPi2b (SCL34A2) Epitope for Antibody Therapy, Antibodies Directed Thereto, and Target for Cancer Therapy
07/10/2014US20140193407 Drug fusions and conjugates
07/10/2014US20140193406 Methods used in identifying glioblastoma
07/10/2014US20140193402 ANTI-PDGFR-beta ANTIBODIES AND USES THEREOF
07/10/2014US20140193399 Anti-CD3 Antibodies And Methods Of Use Thereof
07/10/2014US20140193398 Polymalic acid-based nanobiopolymer compositions
07/10/2014US20140193397 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
07/10/2014US20140193396 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
07/10/2014US20140193363 Novel benzimidazole derivatives
07/10/2014US20140193362 Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
07/10/2014US20140193332 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
07/10/2014US20140193329 Anti-cd151 antibodies and their use in the treatment of cancer
07/09/2014EP2752485A1 NUCLEIC ACID CONSTRUCT INCLUDING NUCLEIC ACID DERIVED FROM GENOTYPE 3a HCV GENOME
07/09/2014EP2752428A1 Humanization of rabbit antibodies using a universal antibody framework
07/09/2014EP2752427A1 Antibodies containing therapeutic TPO/EPO mimetic peptides
07/09/2014EP2752200A1 Antigen-binding molecule inducing immune response to target antigen
07/09/2014EP2752199A1 Rsv mucosal vaccine
07/09/2014EP2752198A1 Vaccine preparation for cancer treatment
07/09/2014EP2752197A1 Medicaments and methods for treating headache in triptan overusers
07/09/2014EP2752193A1 Allogeneic cancer cell-based immunotherapy
07/09/2014EP2752189A1 Use of anti-vegf antibody in combination with chemotherapy for treating breast cancer
07/09/2014EP2751260A2 Live attenuated influenza virus
07/09/2014EP2751139A1 Caninised tumour necrosis factor antibodies and methods of using the same
07/09/2014EP2751130A1 Mycobacterium tuberculosis porins and toxins and related methods
07/09/2014EP2750708A1 Influenza virus antibody compositions
07/09/2014EP2750707A1 Pegylated liposomes for delivery of immunogen-encoding rna
07/09/2014EP2750706A1 2-hydroxyhippuric acid analogs, and methods for their synthesis and use
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 1823